Why is BNB Still Soaring While the Market is Falling?
BNB continued its rise today while other leading digital assets suffered notable losses.
Analysts state that BNB's strong ecosystem usage and capital structure are behind this resistance.
Ethereum fell 1.4% and XRP 0.65% in the last 24 hours, while Bitcoin traded sideways after a negative trend for most of the day. Meanwhile, BNB rose 1.3% in the last 24 hours to trade at $1,293.
Analyst Dean Chen noted that BNB has shown remarkable resilience amid the market-wide pullback:
“BNB's utility within the ecosystem, token economics, and capital structure support this resilience. As Binance's native coin and the underlying gas asset of BNB Chain, on-chain demand continues to grow in DeFi, RWA, gaming, and infrastructure projects.”
Another factor supporting BNB's performance has been increased institutional interest. YZi Labs, the company owned by former Binance CEO Changpeng Zhao, recently announced a $1 billion fund for BNB Chain developers.
“Market interest around CZ’s YZi Labs initiative has strengthened investor confidence and BNB’s long-term outlook,” Chen said.
Chen argued that BNB’s use within the network plays a key role in its durability:
Binance's ongoing auto-burn and quarterly burn mechanisms gradually reduce supply. This structural scarcity strengthens price flexibility as demand increases and provides a robust hedge against market declines.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
Crypto prices
More
